XML 44 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2014
Dec. 31, 2013
Current Assets:    
Cash and cash equivalents $ 305,048 $ 279,058
Accounts receivable, net of reserves of $3,964 in 2014 and $3,533 in 2013 168,641 158,038
Inventories 145,400 133,427
Deferred income tax assets 33,789 33,226
Other current assets 48,829 48,957
Total current assets 701,707 652,706
Long-Term Assets:    
Property and equipment, net 286,712 281,214
Goodwill 181,619 180,521
Intangible assets, net 55,550 58,844
Other long-term assets, net 57,605 57,231
Total long-term assets 581,486 577,810
TOTAL ASSETS 1,283,193 1,230,516
Current Liabilities:    
Accounts payable 41,425 29,941
Accrued liabilities 147,245 148,919
Line of credit 384,000 277,000
Current portion of long-term debt   1,035
Current portion of deferred revenue 27,682 21,458
Total current liabilities 600,352 478,353
Long-Term Liabilities:    
Deferred income tax liabilities 28,815 33,948
Long-term debt, net of current portion 150,000 150,359
Long-term deferred revenue, net of current portion 20,432 18,427
Other long-term liabilities 30,664 31,215
Total long-term liabilities 229,911 233,949
Total liabilities 830,263 712,302
Commitments and Contingencies (Note 14)      
Stockholders' Equity:    
Common stock, $0.10 par value per share: Authorized: 120,000 shares; Issued: 101,628 and 101,188 shares in 2014 and 2013, respectively 10,163 10,119
Additional paid-in capital 856,350 825,320
Deferred stock units: Outstanding: 123 and 122 units in 2014 and 2013, respectively 5,253 5,110
Retained earnings 1,597,196 1,493,393
Accumulated other comprehensive income 15,031 13,622
Treasury stock, at cost: 51,239 and 49,649 shares in 2014 and 2013, respectively (2,031,125) (1,829,378)
Total IDEXX Laboratories, Inc. stockholders' equity 452,868 518,186
Noncontrolling interest 62 28
Total stockholders' equity 452,930 518,214
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 1,283,193 $ 1,230,516